Granadillo Pedro P
SEC-identified person · CIK 1217544 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Rocket Pharmaceuticals, INC. RCKT | Director | filed 2018–2025 |
| Orchestra Biomed Holdings, Inc. OBIO | Director | filed 2020–2020 |
| Immunovant, Inc. IMVT | Director | filed 2019–2019 |
| Haemonetics Corp HAE | Director | filed 2006–2018 |
| NPS Pharmaceuticals INC NSPS | Director | filed 2010–2015 |
| Dendreon Corp DNDNQ | Director · Board of Director | filed 2009–2014 |
| SMI Products INC SPDU | Director | filed 2007–2011 |
| Noven Pharmaceuticals INC NOWN | Director | filed 2006–2009 |
| First Indiana Corp FINB | Director | filed 2006–2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.